Procter & Gamble Health Limited has submitted to the Exchange, the financial results for the period ended September 30, 2025.
PGHL · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Procter & Gamble Health Limited has submitted its unaudited financial results for Q2 FY26 (quarter ended September 30, 2025) along with half-yearly results, to both BSE and NSE. The Board of Directors approved these results at a meeting held on November 5, 2025. Statutory auditor Haribhakti & Co. LLP issued an unmodified Limited Review Report, confirming nothing came to their attention suggesting the results contain any material misstatement. The report also notes that prior-year half-yearly comparison figures were derived by combining published audited Q1 FY25 and unaudited Q2 FY25 numbers.
Routine quarterly compliance filing — no red flags from the auditor. Investors should look at the attached financial results document for actual revenue, profit, and margin numbers to assess performance. A clean review report supports continuity of investor confidence.